ClinicalTrials.gg
Not yet recruitingNCT07765017Updated Aug 14, 2026

Early Mobilization and Prolonged ICU Stay in Postoperative Patients

An observational study in Early Mobilization and Postoperative Care, sponsored by Ankara Training and Research Hospital. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-14.

Sponsored by Ankara Training and Research Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
80
Ages
18 Years and older
Sex
All
01

Study summary

This prospective observational cohort study aims to evaluate early mobilization in adult postoperative patients admitted to the intensive care unit (ICU) and to investigate its association with short-term clinical outcomes. Early meaningful mobilization is defined as achieving at least sitting at the edge of the bed (mobilization level ≥4) within the first 24 hours after ICU admission. Patients will be classified according to whether early meaningful mobilization is achieved. The primary objective is to evaluate the association between early meaningful mobilization and prolonged ICU stay. Secondary outcomes include mechanical ventilation requirement and duration, hospital length of stay, need for reintubation, development of delirium, complications occurring during mobilization, and ICU mortality.

Read the detailed description

This is a prospective observational cohort study involving adult postoperative patients admitted to the intensive care unit (ICU). The study aims to systematically evaluate early mobilization practices and investigate the association between early mobilization and short-term clinical outcomes in postoperative ICU patients.

Mobilization performed within the first 24 hours after ICU admission will be evaluated according to predefined standardized criteria. Mobilization levels will be recorded using a scale ranging from passive movements to independent mobilization. Early meaningful mobilization is defined as achieving at least sitting at the edge of the bed (mobilization level ≥4) within the first 24 hours after ICU admission. Patients will be classified according to whether early meaningful mobilization is achieved.

The primary objective is to evaluate the association between early meaningful mobilization and prolonged ICU stay. Secondary objectives include evaluating its association with the requirement for and duration of mechanical ventilation, hospital length of stay, need for reintubation, development of delirium, complications occurring during mobilization, ICU mortality, and other early clinical outcomes.

Clinical factors potentially associated with the feasibility of early mobilization will also be evaluated. These include age, comorbidities, preoperative functional capacity, type and duration of surgery, APACHE II and SOFA scores at ICU admission, requirement for mechanical ventilation, vasopressor support, and sedation level. In patients who are not mobilized early, potential barriers to mobilization, including hemodynamic instability, respiratory insufficiency, deep sedation, pain, surgical restrictions, and organizational factors, will be recorded.

Patients will be followed throughout their ICU and hospital stay, and relevant clinical outcomes will be recorded. Demographic characteristics, surgical data, clinical parameters at ICU admission, mobilization status, and clinical outcomes will be collected using a standardized data collection form. All collected data will be anonymized for analysis.

No additional intervention or diagnostic test will be performed as part of the study. All study data will be obtained during routine clinical follow-up, directly from included patients, nursing observation forms, and electronic hospital records.

02

Conditions studied

  • Early Mobilization
  • Postoperative Care

Keywords

  • Early Mobilization
  • Postoperative Intensive Care
  • Intensive Care Unit
  • Prolonged ICU Stay
03

In context

Lead sponsor

Ankara Training and Research Hospital is the lead sponsor of 48 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult postoperative patients admitted to the intensive care unit of Ankara Training and Research Hospital who meet the predefined eligibility criteria will constitute the study population. Participants will be prospectively evaluated for early mobilization during their ICU stay and followed for the clinical outcomes specified in the study protocol.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Admission to the intensive care unit for postoperative care
  • ICU stay of at least 24 hours
  • Ability to assess the patient's mobilization level within the first 24 hours following ICU admission
  • Provision of for participation in the study

Exclusion criteria

Exclusion Criteria:

  • Age under 18 years
  • Pregnancy
  • Death within the first 24 hours after ICU admission
  • Clinical conditions contraindicating mobilization, including active massive bleeding, significant hemodynamic instability, unstable fracture, open abdomen, or similar conditions
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Early Meaningful Mobilization

    Postoperative ICU patients who achieve a mobilization level of ≥4 within the first 24 hours after ICU admission.

  • No Early Meaningful Mobilization

    Postoperative ICU patients who do not achieve a mobilization level of ≥4 within the first 24 hours after ICU admission.

06

What researchers measure

Primary outcomes

  1. Prolonged Intensive Care Unit Stay

    Prolonged ICU stay will be evaluated according to the duration of ICU hospitalization and compared between patients who achieve early meaningful mobilization and those who do not. Early meaningful mobilization is defined as achieving a mobilization level of ≥4 within the first 24 hours after ICU admission.

    Time frame: Through ICU stay, an expected average of 3 days

Secondary outcomes

  1. Mechanical Ventilation Requirement

    Requirement for invasive mechanical ventilation during the ICU stay

    Time frame: Through ICU stay, an expected average of 3 days

  2. Duration of Mechanical Ventilation

    Duration of invasive mechanical ventilation during the ICU stay, recorded in days.

    Time frame: Through ICU stay, an expected average of 3 days

  3. Hospital Length of Stay

    Total duration of hospitalization, recorded in days.

    Time frame: Through hospitalization, an expected average of 7 days

  4. Reintubation Requirement

    Occurrence of reintubation during the ICU stay.

    Time frame: Through ICU stay, an expected average of 3 days

  5. ICU Mortality

    All-cause mortality occurring during the ICU stay

    Time frame: Through ICU stay, an expected average of 3 days

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Individual participant data are not planned to be shared because data sharing with external researchers was not included in the approved study protocol.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07765017
Lead sponsor
Ankara Training and Research Hospital
Responsible party
Dilek Kuzukiran Kocatas (Principal Investigator, Ankara Training and Research Hospital) — Principal investigator
First posted
Aug 14, 2026
Start date
Oct 15, 2026 (estimated)
Primary completion
Feb 15, 2027 (estimated)
Completion
May 15, 2027 (estimated)
Last update
Aug 14, 2026

Study contacts

Dilek Kuzukıran Kocataş, MD
Contact
drdilek06@hotmail.com
+905355261001
Dilek Kuzukıran Kocataş, MD
principal investigator · Ankara Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion